| 000 | 01474 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515205147.0 | ||
| 264 | 0 | _c20100325 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/cpp48129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPscherer, S | |
| 245 | 0 | 0 |
_aComparison of one-year costs of type 2 diabetes treatment with insulin glargine or insulin detemir in a basal supported oral therapy (BOT) in Germany. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cFeb 2010 |
||
| 300 |
_a129-37 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xeconomics |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 | _aInsulin Glargine |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReagent Strips _xeconomics |
| 650 | 0 | 4 |
_aSyringes _xeconomics |
| 700 | 1 | _aDietrich, E S | |
| 700 | 1 | _aDippel, F-W | |
| 700 | 1 | _aNeilson, A R | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 48 _gno. 2 _gp. 129-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cpp48129 _zAvailable from publisher's website |
| 999 |
_c19508977 _d19508977 |
||